Antibody

Classic mouse monoclonal antibodies boast stable lot-to-lot quality control performance, featuring high affinity, high specificity and broad application compatibility.

As functional single-domain antibodies with a molecular weight of only 15 kDa, nanobodies feature unique strengths including exceptional stability, the capacity to recognize cryptic epitopes, and convenient genetic engineering modification. They stand out as a new generation of preferred antibody tools for scientific research and industrial diagnostics.

Polyclonal antibodies are produced from the serum of immunized animals and target multiple epitopes on antigens. They deliver robust binding signals, high experimental tolerance, short production cycles and excellent cost-effectiveness. They are ideal for preliminary target verification and short-term research applications.

Secondary antibodies specifically recognize primary antibodies with various labels for signal amplification, compatible with WB, ELISA, IHC, flow cytometry, biomolecular interaction and other assays.

Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.

IVD-specific antibodies undergo rigorous multi-stage quality control, featuring consistent lot-to-lot performance, high specificity and excellent long-term storage stability. Compatible with multiple detection platforms including chemiluminescence, colloidal gold and ELISA, they deliver reliable core raw materials for medical device development and kit mass production.

Neutralizing and blocking antibodies specifically bind to the functional epitopes of antigens, block protein-protein interactions and abrogate biological activities. They are core functional raw materials for target mechanism research and diagnostic reagent development.

Isotype control antibodies match primary antibodies in species and subtype without antigen-specific binding capacity. They effectively distinguish specific positive signals from non-specific background interference and are compatible with flow cytometry, IHC, ELISA and other assays, serving as essential control reagents for target verification and diagnostic reagent development.